HomeCompareMEPDF vs MRK

MEPDF vs MRK: Dividend Comparison 2026

MEPDF yields 2.19% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEPDF wins by $69.7K in total portfolio value· pulled ahead in Year 5
10 years
MEPDF
MEPDF
● Live price
2.19%
Share price
$19.00
Annual div
$0.42
5Y div CAGR
50.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$126.5K
Annual income
$49,895.16
Full MEPDF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MEPDF vs MRK

📍 MEPDF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEPDFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEPDF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEPDF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEPDF
Annual income on $10K today (after 15% tax)
$186.37/yr
After 10yr DRIP, annual income (after tax)
$42,410.89/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MEPDF beats the other by $34,082.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEPDF + MRK for your $10,000?

MEPDF: 50%MRK: 50%
100% MRK50/50100% MEPDF
Portfolio after 10yr
$91.6K
Annual income
$29,846.65/yr
Blended yield
32.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MEPDF
No analyst data
Altman Z
2.8
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEPDF buys
0
MRK buys
0
No recent congressional trades found for MEPDF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEPDFMRK
Forward yield2.19%2.76%
Annual dividend / share$0.42$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR50.2%32.7%
Portfolio after 10y$126.5K$56.8K
Annual income after 10y$49,895.16$9,798.13
Total dividends collected$98.5K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MEPDF vs MRK ($10,000, DRIP)

YearMEPDF PortfolioMEPDF Income/yrMRK PortfolioMRK Income/yrGap
1$11,029$329.33$11,206$366.19$177.00MRK
2$12,311$509.88$12,650$502.35$339.00MRK
3$13,972$798.93$14,407$694.19$435.00MRK
4$16,223$1,272.78$16,585$967.82$362.00MRK
5← crossover$19,433$2,074.47$19,342$1,363.89+$91.00MEPDF
6$24,281$3,488.22$22,913$1,947.19+$1.4KMEPDF
7$32,099$6,118.23$27,662$2,823.89+$4.4KMEPDF
8$45,700$11,353.62$34,159$4,173.35+$11.5KMEPDF
9$71,589$22,690.29$43,337$6,308.80+$28.3KMEPDF
10$126,496$49,895.16$56,776$9,798.13+$69.7KMEPDF

MEPDF vs MRK: Complete Analysis 2026

MEPDFStock

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.

Full MEPDF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MEPDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEPDF vs SCHDMEPDF vs JEPIMEPDF vs OMEPDF vs KOMEPDF vs MAINMEPDF vs JNJMEPDF vs ABBVMEPDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.